Continuous Hemofiltration in the Treatment of Acute Renal Failure

Total Page:16

File Type:pdf, Size:1020Kb

Continuous Hemofiltration in the Treatment of Acute Renal Failure CURRENT CONCEPTS Review Article Current Concepts normalization of the plasma as possible. Thus, the sodium concentration of the dialysis fluid is physio- logic, but the potassium concentration is lower than that of normal plasma in order to establish a gradi- CONTINUOUS HEMOFILTRATION IN ent from plasma to the fluid that promotes the re- THE TREATMENT OF ACUTE RENAL moval of potassium ions from the patient’s blood. The concentrations of substances that are to be re- FAILURE moved completely (such as urea, creatinine, and phosphate) are zero in the dialysis fluid. The remov- L.G. FORNI, M.B., PH.D., AND P.J. HILTON, M.D. al of salt and water is achieved by the creation of a transmembrane pressure gradient (with lower pres- sure in the dialysis-fluid compartment). According CUTE renal failure that requires renal- to the laws of diffusion, the larger the molecule, the replacement therapy is a relatively common slower will be its rate of transfer across the mem- condition, with an annual incidence of at brane. A small molecule, such as urea (60 daltons), A 1 least 30 cases per 1 million population. Historically, is cleared efficiently, and a larger molecule, such as the replacement of renal function in acute renal fail- creatinine (113 daltons), less well. Phosphate ions ure has involved techniques also employed in the have such low rates of clearance that hyperphos- treatment of end-stage chronic renal failure — inter- phatemia is always a problem for patients on inter- mittent hemodialysis and peritoneal dialysis.2,3 Hemo- mittent dialysis. Dialysis has no similarity to the nor- filtration was first described in 1977 as a means of mal physiologic processes of the kidney, but it is removing extracellular fluid from patients with ede- effective, and many patients have lived for decades ma refractory to diuretic agents.4 Continuous hemo- entirely dependent on intermittent hemodialysis.5 filtration, combined with the administration of an Hemofiltration (Fig. 1, lower panel) works in a appropriate fluid, is now recognized as a form of re- different manner.6,7 In the simplest form of the pro- nal-replacement therapy in acute renal failure. The cedure, blood under pressure passes down one side technique is widely used in intensive care units for of a highly permeable membrane allowing both wa- the treatment of acute renal failure, although inter- ter and substances up to a molecular weight of about mittent hemodialysis continues to be used for pa- 20,000 to pass across the membrane by convective tients with acute renal failure but without multior- flow, as in glomerular filtration. During hemofiltra- gan failure. tion, in contrast to hemodialysis, urea, creatinine, and phosphate are cleared at similar rates, and pro- BASIC PRINCIPLES found hypophosphatemia may develop unless the Hemofiltration has many superficial similarities to patient’s phosphate intake is supplemented. Larger hemodialysis. In both techniques, access to the cir- molecules such as heparin, insulin, myoglobin, and culation is required and blood passes through an ex- vancomycin, which are cleared from the blood in tracorporeal circuit that includes either a dialyzer or only negligible quantities in a dialyzer, are cleared a hemofilter. However, the mechanisms by which the efficiently by the hemofilter. composition of the blood is modified differ marked- In the kidney, the glomerular filtrate is selectively ly (Fig. 1). During dialysis (Fig. 1, upper panel), blood reabsorbed by the renal tubules, a process too com- flows along one side of a semipermeable membrane plex to be artificially reproduced with current tech- as a solution of crystalloids is pumped along the oth- nology. Instead, during hemofiltration, the filtrate is er side of the membrane against the direction of the discarded and the patient receives infusions (usually blood flow. Small molecules diffuse across the mem- through the distal part of the hemofiltration circuit) brane from regions of greater concentration to re- of a solution in which the major crystalloid compo- gions of lesser concentration, and the composition nents of the plasma are at physiologic levels (the typ- of the dialysis fluid is designed to produce as near ical composition of hemofiltration replacement fluid is shown in Table 1). If there is no need for the re- moval of fluid from the patient, the rate at which the replacement fluid is administered is matched exactly with the rate of production of hemofiltrate. Usually, From St. Thomas’ Hospital, London SE1 7EH, United Kingdom, where reprint requests should be addressed to Dr. Hilton. however, there is a need to remove fluid, because of ©1997, Massachusetts Medical Society. either fluid overload or the clinical need to adminis- Volume 336 Number 18 ؒ 1303 The New England Journal of Medicine Hemodialysis Urea Phosphate K+ Creatinine Urea Phosphate K+ Creatinine K+ Creatinine Phosphate Urea To From patient K+ Creatinine Phosphate Urea patient Dialysis fluid Dialysate Hemofiltration Replacement fluid + + Na HH2OK HH2O Phosphate H2O Creatinine H2O Na+ K+ Phosphate Creatinine K+ Phosphate Na+ Urea To From patient patient + + K HH2O Phosphate H2O Na HH2O Urea H2O Hemofiltrate Figure 1. Hemodialysis and Hemofiltration. The arrows that cross the membrane indicate the predominant direction of movement of each solute through the membrane; the relative size of the arrows indicates the net amounts of the solute transferred. Other arrows indicate the direction of flow. ter fluids to a patient with oliguria. A net loss of ex- the principal constituents of the filtrate. Hemofiltra- tracellular fluid is achieved by replacing less fluid tion therefore inevitably leads to an increase in the through infusion than is removed by hemofiltration. concentration of both red cells and plasma protein It is important to recognize that certain physical in the blood of the extracorporeal circuit8; there is constraints affect hemofiltration as they do glomer- thus a tendency to produce viscous blood of high ular filtration. In both processes, the plasma compo- hematocrit and high colloid oncotic pressure at the nent of the blood flowing through the circuit repre- distal end of the hemofilter. It is therefore generally sents the sole source of the salt and water that are unwise to induce a filtration rate that is more than May 1, 1997 ؒ 1304 CURRENT CONCEPTS care unit, a number of variants were developed (Ta- TABLE 1. TYPICAL COMPOSITION ble 2). These are outlined below. OF HEMOFILTRATION REPLACEMENT FLUID.* CONTINUOUS ARTERIOVENOUS COMPONENT VALUE HEMOFILTRATION mmol/ Continuous arteriovenous hemofiltration is the liter original and simplest form of the technique.4,9 The Sodium 140 femoral artery and vein are cannulated, and blood Potassium 0 passes through the hemofilter under the influence of Calcium 1.6 arterial pressure alone (Fig. 2). Because the pressure Magnesium 0.75 in the system exceeds the atmospheric pressure, Chloride 101 there is no possibility of air being drawn into the cir- Lactate 45 cuit and no precautions need to be taken to prevent Glucose 11 this from occurring. However, the simplicity of the *The values shown are for Gambro Hemofiltrasol system is offset by several disadvantages. First, a dis- 22. Potassium chloride is added to the solution im- connection or leak in the circuit can result in rapid mediately before use in concentrations of up to loss of blood. Second, the efficiency of hemofiltra- 4 mmol per liter, depending on the serum potassium concentration. To convert the value for calcium to tion depends on the arterial pressure, which is fre- milligrams per deciliter, divide by 0.25; to convert quently low or unstable in patients with acute renal the value for magnesium to milliequivalents per liter, failure. The effectiveness of the system is therefore divide by 0.5; and to convert the value for glucose to milligrams per deciliter, divide by 0.05551. determined mainly by factors outside the direct con- trol of the physician. Low blood flow is associated with frequent clotting of the extracorporeal circuit, and the prolonged arterial cannulation typically used carries a risk of complications at the puncture site. 30 percent of the blood-flow rate. Keeping the ratio Continuous arteriovenous hemofiltration often re- between the two rates under 25 percent minimizes sults in clearance rates as low as 10 to 15 ml per the unwanted effect. An alternative approach, known minute even in normotensive patients; clearance rates as predilution, circumvents the problem by adminis- may drop to below 10 ml per minute if a patient has tering the replacement fluid proximal to the hemo- marked hypotension. filter. This rarely used procedure reduces the ef- ficiency and increases the cost of hemofiltration CONTINUOUS ARTERIOVENOUS because a proportion of the generated filtrate is ac- HEMODIALYSIS WITH FILTRATION tually replacement fluid. The recognition of the inadequacy of continuous As hemofiltration became an increasingly popular arteriovenous hemofiltration when used alone led to form of renal-replacement therapy in the intensive the addition of a dialysis circuit to the hemofilter.10,11 TABLE 2. TYPES OF RENAL-REPLACEMENT THERAPY FOR ACUTE RENAL FAILURE. EXTRA- ANTI- CELLULAR-FLUID USE IN COAGULANT RISK OF RISK OF VOLUME HYPO- TYPE COMPLEXITY EFFICIENCY COST THERAPY HEMORRHAGE INFECTION CONTROL TENSION Peritoneal dialysis Low Moderate Moderate No Low High Moderate Yes Intermittent hemodialysis Moderate High Low Yes Moderate Low Intermittent No Continuous arteriovenous Moderate Low and Moderate
Recommended publications
  • Interaction Between Renal Replacement Therapy And
    rren Cu t R y: es Romano, Surgery Curr Res 2014, 4:1 r e e a g r r c u h DOI: 10.4172/2161-1076.1000154 S Surgery: Current Research ISSN: 2161-1076 Review Article Open Access Interaction between Renal Replacement Therapy and Extracorporeal Membrane Oxygenation Support Thiago Gomes Romano* Assistant Teaching Professor for the Discipline of Nephrology, ABC Medical School Medical Intensivist at Hospital, Sírio-Libanês, Brazil Abstract Extracorporeal Membrane Oxygenation (ECMO) is one of the designations used for extracorporeal circuits capable of oxygenation, carbon dioxide removal and, eventually, circulatory support. Acute respiratory distress syndrome with severe hypoxemia or acidemia with high carbon dioxide levels in a scenario of low pulmonary tidal volume is its mainly indication. Acute Kidney Injury (AKI) and its complications such as volume overload and azotemia are common in this situation; some epidemiological studies have shown that around 78% of the patients demanding ECMO therapy develop AKI. Therefore, renal replacement therapy is required in about 50% of those cases. This papers aims to explain the concept of the ECMO circuit and the ways continuous renal replacement therapy (CRRT) can be instituted in critical ill patients who need ECMO. Keywords: ECMO; Renal replacement therapy; Dialysis internal jugular or femoral vein with the return placed in the femoral artery. Additionally, a jugular-carotid cannulation is one option despite Introduction the potential for neurological injury. In cases exclusively intended for Extracorporeal Membrane Oxygenation (ECMO) is one of the ventilatory support [venovenous (VV) ECMO], cannulation can be designations used for extracorporeal circuits capable of oxygenation, placed femoro-jugular, jugular-femoral or femoral-femoral depending carbon dioxide (CO ) removal and, eventually, circulatory support.
    [Show full text]
  • Targeted High Volume Hemofiltration Could Avoid Extracorporeal Membrane Oxygenation in Some Patients with Severe Hantavirus Cardiopulmonary Syndrome
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 5 July 2020 doi:10.20944/preprints202007.0046.v1 Article Targeted High Volume Hemofiltration Could Avoid Extracorporeal Membrane Oxygenation in Some Patients with Severe Hantavirus Cardiopulmonary Syndrome René López1, 2, Rodrigo Pérez-Araos1, 3, Álvaro Salazar1, Mauricio Espinoza1, 2, Cecilia Vial4, Analia Cuiza 4, Pablo A. Vial2, 4, 5, and Jerónimo Graf1, 2* 1. Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago 7650567, Chile; [email protected] (R.L.); [email protected] (R.P-A.); [email protected] (Á .S.); [email protected] (M.E); [email protected] (J.G.) 2. Escuela de Medicina. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile; [email protected] (P.A.V.) 3. Escuela de Kinesiología. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile 4. Programa Hantavirus, Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7590943, Chile; [email protected] (C.V.); [email protected] (A.C.) 5. Departamento de Pediatría, Clínica Alemana de Santiago, Santiago 7650567, Chile Correspondence: [email protected] Abstract Background: Hantavirus cardiopulmonary syndrome (HCPS) has a high lethality. About two-thirds of the severe cases may be rescued by extracorporeal membrane oxygenation (ECMO). However, about half of the patients supported by ECMO suffer major complications. High volume hemofiltration (HVHF) is a depurative extracorporeal support that provides homeostatic balance allowing hemodynamic stabilization in some critically ill patients. Methods: We implemented HVHF prior to ECMO consideration in the last five severe HCPS patients requiring mechanical ventilation and vasoactive drugs admitted to our intensive care unit.
    [Show full text]
  • Overview of Complications of Hemodialysis Access
    Update on Hemodialysis Access Raymond J. Holmes, MD April 4th, 2019 Presenter Disclosure Information Raymond J. Holmes, MD The Cardiovascular Care Group FINANCIAL DISCLOSURE: Nothing to disclose UNLABELED/UNAPPROVED USES DISCLOSURE: No unlabeled and or unapproved off-label use of products or devices will be discussed in this presentation Update on Hemodialysis Access Surgery • Overview: K-DOQI and Fistula First • Strategy for sequential access placement • AV fistula, AV graft, basilic vein transposition, HeRO device • Endovascular Intervention • Complications In the Beginning… Belding Scribner 1921-2003 Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula Michael J. Brescia, M.D., James E. Cimino, M.D., Kenneth Appel, M.D. and Baruch J. Hurwich, M.D. NEJM 275:1089-1092, 1966. James E. Cimino (1928-2010) What is the best access for hemodialysis? • 53 years after initial description of the AV fistula, it still remains the best access for hemodialysis Michael J. Brescia, M.D., James E. Cimino, M.D., Kenneth Appel, M.D. and Baruch J. Hurwich, M.D. NEJM 275:1089-1092, 1966. DOQI Guidelines • Developed by National Kidney Foundation. (www.kidney.org) • Common sense, common practice • Some “evidence” based; some opinion based. • Careful disclaimers not to be “standard of care” – However, widely adapted as “standard of care”. Guidelines on topics for management of patients with chronic kidney disease including vascular access •Clinical Practice Guidelines for Vascular Access, Update 2006 •Guideline 1. Patient Preparation for Permanent Hemodialysis Access •Guideline 2. Selection and Placement of Hemodialysis Access •Guideline 3. Cannulationof Fistulae and Grafts and Accession of Hemodialysis Catheters and Port Catheter Systems •Guideline 4.
    [Show full text]
  • Hemodialysis
    The Ohio State University Veterinary Medical Center Hemodialysis What is hemodialysis? Hemodialysis is a method of blood purification that This is most commonly performed in the acute setting removes blood from the body through a catheter (acute kidney injury) for animals but may also be elected and filters it through a dialyzer (artificial kidney). for patients with chronic kidney dysfunction. Hemodialysis is used to purify the blood by eliminating While acute kidney injury is the most common reason toxic metabolites, balancing electrolytes, and removing for performing hemodialysis, it can also be used to treat excess water that builds up when the kidneys are acute intoxications to enhance elimination of a toxin. unable to excrete it. Indications for Hemodialysis Acute Kidney Injury This is the most common indication for hemodialysis. 10-14 days of hospitalization and treatment. With acute This procedure should be considered when clinical kidney injury, the kidneys typically start to regain some uremia, hyperkalemia, acid/base disturbances, and function within this time period, but a lack of response fluid overload cannot be managed with conventional does not mean the kidneys will never recover. medical therapy. The best time to start hemodialysis There are instances when it may take up to four weeks is still unknown (even in human medicine), but starting to become dialysis independent. Patients are generally treatment sooner means fewer side effects from uremia. transitioned after the 10-14 days to outpatient treatments Thus, hemodialysis should be considered sooner rather to continue to provide time for the kidneys to recover. than later. Outpatient treatments allow families to play an active When hemodialysis is performed, pet owners should role in facilitating recovery.
    [Show full text]
  • UNDERSTANDING YOUR HEMODIALYSIS OPTIONS Hemodialysis Is a Treatment for Access People Whose Kidneys Are No Longer Involves Working
    UNDERSTANDINGUnderstanding YOUR HEMODIALYSISYour OPTIONS Hemodialysis Access Options This educational activity is supported by a donation by Amgen, Inc UNDERSTANDING YOUR HEMODIALYSIS OPTIONS Hemodialysis is a treatment for access people whose kidneys are no longer involves working. The treatment removes making a waste products and fluid from the connection blood using an artificial kidney between an machine. It is the most common artery and a treatment for people who have end- vein under stage renal disease (ESRD), or whose the skin. A kidneys no longer work. surgeon will make There are four types of hemodialysis your fistula treatment options. AAKP created this or graft brochure to explain each of your by sewing treatment options, and to show you one of your the pros and cons of each option. arteries to Mayo Clinic Foundation for one of your Education and Research veins. It’s CREATING AN ACCESS a simple medical procedure. Your surgeon Before you begin hemodialysis chooses which artery and vein to treatment, a surgeon must create connect depending on how fast your an access for the machine. Don’t be blood flows through the artery and afraid. Access for the machine will vein. be at a place on your body close to a vein and artery. It allows access A catheter is the other type of to your blood stream. Blood goes access. A catheter is a thin, flexible from your body through the access tube that can be put through a small and to the dialysis machine. Once hole in your body. A surgeon inserts inside the artificial kidney machine, the catheter through your skin into the machine cleans the blood and a large vein in the neck, chest or returns the clean blood back to groin.
    [Show full text]
  • Induced Nephropathy by Hemofiltration
    The new england journal of medicine original article The Prevention of Radiocontrast-Agent– Induced Nephropathy by Hemofiltration Giancarlo Marenzi, M.D., Ivana Marana, M.D., Gianfranco Lauri, M.D., Emilio Assanelli, M.D., Marco Grazi, M.D., Jeness Campodonico, M.D., Daniela Trabattoni, M.D., Franco Fabbiocchi, M.D., Piero Montorsi, M.D., and Antonio L. Bartorelli, M.D. abstract background Nephropathy induced by exposure to radiocontrast agents, a possible complication of From the Centro Cardiologico Monzino, percutaneous coronary interventions, is associated with significant in-hospital and long- Istituto di Ricovero e Cura a Carattere Sci- entifico, Institute of Cardiology, Universi- term morbidity and mortality. Patients with preexisting renal failure are at particularly ty of Milan, Milan, Italy. Address reprint high risk. We investigated the role of hemofiltration, as compared with isotonic-saline requests to Dr. Marenzi at Centro Cardio- hydration, in preventing contrast-agent–induced nephropathy in patients with renal logico Monzino, Via Parea 4, 20138 Milan, Italy, or at giancarlo.marenzi@ failure. cardiologicomonzino.it. methods N Engl J Med 2003;349:1333-40. We studied 114 consecutive patients with chronic renal failure (serum creatinine con- Copyright © 2003 Massachusetts Medical Society. centration, >2 mg per deciliter [176.8 µmol per liter]) who were undergoing coronary interventions. We randomly assigned them to either hemofiltration in an intensive care unit (ICU) (58 patients, with a mean [±SD] serum creatinine concentration of 3.0±1.0 mg per deciliter [265.2±88.4 µmol per liter]) or isotonic-saline hydration at a rate of 1 ml per kilogram of body weight per hour given in a step-down unit (56 patients, with a mean serum creatinine concentration of 3.1±1.0 mg per deciliter [274.0±88.4 µmol per liter]).
    [Show full text]
  • Ultrafiltration I Hemodialysis During Cardiopulmonary Bypass: a Case Report
    THE jOURNAL OF EXTRA-CORPOREAL TECHNOLOGY Case Report Ultrafiltration I Hemodialysis During Cardiopulmonary Bypass: A Case Report Scott D. Niles, BA, Robin G. Sutton, MS, CCP, Richard P. Embrey, MD University of Iowa Hospitals and Clinics, Iowa City, Iowa Keywords: cardiopulmonary bypass; hemodialysis, concurrent; technique; ultrafiltration. ABSTRACT Patient demographics for elective cardiovascular surgery have shifted toward older patients with more profound disease states. Cardiopulmonary bypass is complicated when the patient presents with end stage renal disease. Hemodialysis during cardiopulmonary bypass has been successfully employed to reduce the postoperative sequelae associated with cardiopulmo­ nary bypass. A patient with end stage renal disease who presented for coronary artery bypass grafting serves as the subject of this case report. Utilizing a modified technique previously described by Wiggins and Dearing, we describe successful intraoperative use of hemodialysis during cardiopulmonary bypass. Our experience suggests that hemodialysis during cardiopulmo­ nary bypass is an effective alternative to ultrafiltration and may prolong the time interval for resumption of postoperative dialysis regimens. Address correspondence to: Scott D. Niles University of Iowa Hospitals and Clinics Perfusion Technology Program Department of Surgery Division of Cardiothoracic Surgery 1600 JCP Iowa City, lA 52242 104 Volume 27, Number 2, June 1995 THE jOURNAL OF EXTRA-CORPOREAL TECHNOLOGY INTRODUCTION helping to resolve elevated BUN and creatinine levels. A hemodialysis circuit was constructed in parallel with the Population demographics in patients undergoing elective cardiopulmonary bypass circuit (Figure 1). A purge port on top cardiovascular surgery have undergone dramatic changes over of the arterial filter served as the blood source for an ultrafiltration the past twenty years, With a trend toward older patients with hemoconcentrator which then emptied into a venous reservoir bag.
    [Show full text]
  • Preparing for Vascular Access Surgery
    Form: D-5134 Preparing for Vascular Access Surgery Information for patients and families Read this booklet to learn: • why you need vascular access for hemodialysis • what an AV graft and an AV fistula is • what to expect with this procedure • who to call if you have any questions Check in at: Toronto General Hospital Surgical Admission Unit (SAU), Peter Munk Building – 2nd Floor Date and time of my surgery: Date: Time: *Remember: You need to arrive at the hospital 2 hours before surgery Why do I need vascular access surgery? If you need hemodialysis, you need a vein that is easy to find and use. Vascular access surgery makes an access site for the hemodialysis. This is called an arteriovenous (AV) access. An AV access connects your artery directly to your vein. If this is not possible, a soft plastic tube will be used to connect your artery and vein. How does my AV access work during hemodialysis? Before hemodialysis (or dialysis), your nurse will put 2 needles into your AV access. One needle takes the blood from your body to the artificial kidney (dialyzer). This cleans your blood. The second needle returns the clean blood back to you. Only a small amount of blood (about 1 cup) is removed from your body at one time. At the end, your nurse removes both needles and puts bandages where the needles were put in. You can take the bandages off the next day. 2 Your AV access will usually be in your forearm or upper arm. There are 2 types of AV access your surgeon could give you.
    [Show full text]
  • Uremic Toxins and Blood Purification: a Review of Current Evidence and Future Perspectives
    toxins Review Uremic Toxins and Blood Purification: A Review of Current Evidence and Future Perspectives Stefania Magnani * and Mauro Atti Aferetica S.r.l, Via Spartaco 10, 40138 Bologna (BO), Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0535-640261 Abstract: Accumulation of uremic toxins represents one of the major contributors to the rapid progression of chronic kidney disease (CKD), especially in patients with end-stage renal disease that are undergoing dialysis treatment. In particular, protein-bound uremic toxins (PBUTs) seem to have an important key pathophysiologic role in CKD, inducing various cardiovascular complications. The removal of uremic toxins from the blood with dialytic techniques represents a proved approach to limit the CKD-related complications. However, conventional dialysis mainly focuses on the removal of water-soluble compounds of low and middle molecular weight, whereas PBTUs are strongly protein-bound, thus not efficiently eliminated. Therefore, over the years, dialysis techniques have been adapted by improving membranes structures or using combined strategies to maximize PBTUs removal and eventually prevent CKD-related complications. Recent findings showed that adsorption-based extracorporeal techniques, in addition to conventional dialysis treatment, may effectively adsorb a significant amount of PBTUs during the course of the sessions. This review is focused on the analysis of the current state of the art for blood purification strategies in order to highlight their potentialities and limits and identify the most feasible solution to improve toxins removal effectiveness, exploring possible future strategies and applications, such as the study of a synergic approach by reducing PBTUs production and increasing their blood clearance.
    [Show full text]
  • ECMO) Machines
    Converting Hemodialysis (HD) membranes to Extracorporeal Membrane Oxygenation (ECMO) machines Abhimanyu Dasa, Matthew L. Robinsonb, D. M. Warsingera a School of Mechanical Engineering and Birck Nanotechnology Center, Purdue University, West Lafayette, IN, 47907, USA b Division of Infectious Diseases, Center for Clinical Global Health Education, Johns Hopkins University School of Medicine, Baltimore, Maryland April 2020 ABSTRACT Crises like COVID-19 can create a massive unmet demand for rare blood oxygenation membrane machines for impaired lungs: Extracorporeal Membrane Oxygenation (ECMO) machines. Meanwhile, Hemodialysis (HD) machines, which use membranes to supplement failing kidneys, are extremely common and widespread, with orders of magnitude more available than for ECMO machines[1]. This short study examines whether the membranes for HD can be modified for use in blood oxygenation (ECMO). To do so, it considers mass transfer at the micro-scale level, and calculations for the macro-scale level such as blood pumping rates and O2 supply pressure. Overall, while this conversion may technically be possible, poor gas transport likely requires multiple HD membranes for one patient. INTRODUCTION Background on HD and ECMO HD and ECMO machines both operate by removing large volumes of blood from the body and passing them through membranes that rely on diffusion to transfer desirable or undesirable solutes. HD machines focus on adding and removing compounds to assist with kidney failure, including removing salts and small organic compounds like urea. Meanwhile, ECMO uses membranes to replace O2 and help remove CO2. Conversion approach requirements for HD for ECMO Custom HD machines made for blood oxygenation[2] have been successfully demonstrated in the past; the question is whether existing HD machines can be converted readily.
    [Show full text]
  • Ankle-Brachial Blood Pressure Index Predicts All-Cause and Cardiovascular Mortality in Hemodialysis Patients
    J Am Soc Nephrol 14: 1591–1598, 2003 Ankle-Brachial Blood Pressure Index Predicts All-Cause and Cardiovascular Mortality in Hemodialysis Patients KUMEO ONO,* AKIYASU TSUCHIDA,† HIRONOBU KAWAI,ʈ HIDENORI MATSUO,‡ RYOUJI WAKAMATSU,§ AKIRA MAEZAWA,¶ SHINTAROU YANO,¶¶ TOMOYUKI KAWADA,# and YOSHIHISA NOJIMA@ for the GUNMA Dialysis and ASO Study Group *Kan-etsu Chuo Hospital, †Toho Hospital, ʈMaebashi Saiseikai Hospital, ‡Hidaka Hospital, §Nishikatakai Clinic, ¶Wakaba Hospital, ¶¶ Hirosegawa Clinic, #Department of Public Health, Gunma University School of Medicine, and @Third Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan. Abstract. A reduction in ankle-brachial BP index (ABPI) is icantly higher in patients with lower ABPI than those with associated with generalized atherosclerotic diseases and pre- ABPI Ն 1.1 to Ͻ1.3. During the study period, 77 cardiovas- dicts cardiovascular mortality and morbidity in several patient cular and 41 noncardiovascular fatal events occurred. On the populations. However, a large-scale analysis of ABPI is lack- basis of Cox proportional hazards regression analysis, ABPI ing for hemodialysis (HD) patients, and its use in this popula- emerged as a strong independent predictor of all-cause and tion is not fully validated. A cohort of 1010 Japanese patients cardiovascular mortality. After adjustment for confounding undergoing chronic hemodialysis was studied between Novem- variables, the hazard ratio (HR) for ABPI Ͻ 0.9 was 4.04 (95% ber 1999 and May 2002. Mean age at entry was 60.6 Ϯ 12.5 yr, confidence interval, 2.38 to 6.95) for all-cause mortality and and duration of follow-up was 22.3 Ϯ 5.6 mo.
    [Show full text]
  • Providing Continuous Renal Replacement Therapy in Patients on Extracorporeal Membrane Oxygenation
    Kidney Case Conference: How I Treat Providing Continuous Renal Replacement Therapy in Patients on Extracorporeal Membrane Oxygenation Nithin Karakala and Luis A. Juncos CJASN 15: 704–706, 2020. doi: https://doi.org/10.2215/CJN.11220919 Nephrology Section, Case Presentation vein or by using two catheters; one in the internal Central Arkansas A 34-year-old male was admitted for respiratory jugular and one in the femoral vein. VV-ECMO is used Veterans Healthcare fl System, Little Rock, failure due to H1N1 in uenza. His hypoxia worsened in refractory hypoxemia (2). Arkansas despite maximal ventilator support and thus initiated Department of on venovenous extracorporeal membrane oxygena- Medicine/ tion (VV-ECMO). Whereas this stabilized his respira- AKI and Extracorporeal Membrane Oxygenation Nephrology, tory and hemodynamic status, his creatinine increased Patients on ECMO are severely ill and frequently University of Arkansas . for Medical Sciences, (from 1.2 to 2.4 mg/dl), urine output declined (despite develop AKI; its incidence is 50% in adults, more Little Rock, Arkansas furosemide), and his weight had increased from 79 to than one-half of whom require KRT (3). The etiology 92 kg. Ultrasound assessment revealed a noncollaps- of AKI in these patients is comparable to that in Correspondence: ing vena cava and B-lines in his lungs. Nephrology critically ill patients not on ECMO, except that ECMO- Dr. Luis A. Juncos, was consulted for management of AKI and vol- related variables (e.g., hemorheological variations, Central Arkansas ume overload. systemic inflammation, hemolysis, etc.) can also pro- Veterans Healthcare System, 4300 W. 7th mote AKI (2).
    [Show full text]